Spotlight on cancer—covering all bases at UEG Week 2014

October 17, 2014 By: Pedro Borralho

Spotlight on cancer—covering all bases at UEG Week 2014

Time is ticking away to UEG Week 2014 and if fighting cancer makes you tick, you are about to enjoy a full-course week, with servings from a cutting-edge research programme on cancer screening, diagnosis and prevention, and treatment.

If you're an early bird, you might decide to start your UEG Week 2014 experience on Saturday by attending the postgraduate teaching programme, with a mid-morning session dedicated to pancreatic adenocarcinoma, which covers endoscopic ultrasound, radiology and pathology for differential diagnosis, resectability and novel systemic treatment options. Sunday is a busy day and kicks off early morning with a session on colorectal cancer (CRC), focusing on early detection and local treatment, with talks on colonoscopy and non-invasive tests in population screening, and on recognition and diagnosis of early (T1) cancer: endoscopy, histopathological diagnosis and the use of ESD or TEM. This session is followed by one on terminal GI cancer, focused on symptom management and patient care (including case presentations).

If you are only arriving on Monday, no worries! You are just in time to get in gear for the opening plenary session, which includes a talk on advances in the management of CRC, and is followed later in the morning by a free paper session focusing on the clinico-pathological features of GI cancer. During the lunch break you may want to electronically browse through the posters at the E-poster exhibition, and attend the new 'Poster Champ' sessions (from Monday to Wednesday), to select and award the best posters in each category. The afternoon programme includes plenty of sessions for you to choose from, starting with a free paper session on imaging techniques in colonoscopy, followed by another on new diagnostic modalities in upper GI endoscopy. In parallel, from a cancer treatment perspective, the session on late breaking digestive oncology abstracts is very appealing, and just prior to a session on the current and future perspectives in pancreatic cancer.

Tuesday begins with a session on funding available for research under the EU research framework programme (H2020), followed by a 'Posters in the Spotlight' session on "Mechanisms underlying the development of GI cancer". This format is new for UEG Week 2014, in which hot topic research E-posters are presented on stage, and an oral free paper prize will be presented to the best poster. The afternoon kicks off with a free paper session on novel mechanisms and targets in CRC, followed by two sessions focusing on endoscopic management of early colorectal neoplasia and treatment of liver metastases.

Wednesday wraps up this year's exciting and vibrant UEG Week, starting with novel approaches to rectal cancer from the viewpoint of the pathologist and the endoscopist. The final afternoon starts off with a round table discussion on molecular guided therapy for GI cancer, and ends with a session on the pancreas, in which an annual review of pancreatic cancer will be presented from basic and clinic viewpoints. 

To make sure you're not missing out, please do complement this brief by browsing the complete programme online or by viewing the cancer pathway, which can be accessed online or via the UEG Week App

We'd also love to hear what cancer content you find appealing throughout the meeting. Tweet to let us know! #UEGWeek #GIcancer #UEGEducation.

On a footnote, since you can't physically be in two places at once (yet!), UEG will be livestreaming many of the sessions as they happen via UEG Week Live and all recorded talks will be made available via UEG 24/7.

About the author

Dr Pedro Borralho is a Senior Scientist at the Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy (FFULisboa), University of Lisbon, Portugal. He graduated in Biotechnology Engineering in 2004 and performed his PhD studies on miRNAs in colon cancer at FFULisboa and the Gastroenterology, Hepatology and Nutrition Division at the University of Minnesota Medical School, USA, completing his PhD in Pharmacy-Biochemistry in 2009. He has authored/co-authored 25 articles in international, peer-reviewed scientific journals. His research focuses on the exploration and modulation of molecular mechanisms underlying colon cancer onset, progression and therapeutic response, with a strong focus on miRNAs and their therapeutic modulation in cancer.

 

Comments

No comments

More Education News